(redirected from amaurosis fugax)
Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.


Total loss of vision, especially when occurring without pathological changes to the eye.

[Greek amaurōsis, from amauroun, to make dim, from amauros, dark.]

am′au·rot′ic (-rŏt′ĭk) adj.


(Medicine) pathol blindness, esp when occurring without observable damage to the eye
[C17: via New Latin from Greek: darkening, from amauroun to dim, darken]
amaurotic adj


(ˌæm ɔˈroʊ sɪs)

partial or total loss of sight, esp. in the absence of a gross lesion or injury.
[1650–60; < Greek: darkening, hindrance to sight]
am`au•rot′ic (-ˈrɒt ɪk) adj.


a condition of partial or total blindness, caused by a disease of the optie nerve. — amaurotic, adj.
See also: Blindness
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.amaurosis - partial or total loss of sight without pathology of the eyeamaurosis - partial or total loss of sight without pathology of the eye; caused by disease of optic nerve or retina or brain
vision defect, visual defect, visual disorder, visual impairment - impairment of the sense of sight
References in periodicals archive ?
of episodes Amaurosis fugax 1 Angle closure glaucoma 1 Anterior uveitis/iritis 1 Corneal abrasion 1 Corneal ulcer 1 Herpes keratitis 3 Malignant BCC/SCC/SGC 1 Marginal keratitis 2 Septal cellulitis/peri-orbital 3 Retinal tear/hole 5 Scleritis 3 Viral conjunctivitis 1 Wet AMD 1 Figure 1 Appropriateness of optometrist referral (was the referral appropriate based on outcome of assessment?
Amaurosis fugax is a sudden decline in vision of one or both eyes and is more common in a TIA than a stroke (www.
In the anterior circulation, vascular syndromes involving the internal carotid artery are characterized by the ipsilateral monocular temporary vision loss known as amaurosis fugax, which may or may not be accompanied by contralateral weakness or sensory changes.
John immediately suspected amaurosis fugax - a temporary lack of blood flow to the retina which may be a sign of an impending stroke.
Patients with amaurosis fugax, severe stenosis and a high risk profile should be considered for CEA; those with amaurosis fugax and few risk factors do better with medical treatment.
While these lesions are often asymptomatic, the initial clinical manifestations may include transient ischemic attacks (TIA), transient monocular blindness or amaurosis fugax, and focal, persistent neurological deficits related to a CVA.
Ten patients were asymptomatic, one had amaurosis fugax, four had transient ischemic attack within last four months, one had drop attacks, one had headache, seven had the findings of hemiparesis and three had hemiplegia.